NDC 43378-122 - Zodryl DEC 35
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43378-122
- Package NDCs from labels
- 43378-122-04
- Manufacturer
- CodaDose, Inc. | Gorbec Pharmaceutical Services Inc.
- Effective date
- 2009-09-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zodryl DEC 35 - CodaDose, Inc. | Gorbec Pharmaceutical Services Inc. | CodaDose, Inc. | Gorbec Pharmaceutical Services Inc. | 2009-09-11 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43378-122-04 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d845-621f-e053-dbdaa90a74ad | ZODRYL DEC 35 - codeine phosphate, guaifenesin and pseudoephedrine hydrochloride suspension |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43378-122-04 | Zodryl DEC 35 | 118 mL in 1 BOTTLE, PLASTIC | SUSPENSION | 118 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43378-122-04 | ML - Milliliter | 43378-122 | b282f40b-1804-4344-a1cd-cb4962b51c72 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACTINEL | DEXTROMETHORPHAN HBR,GUAIFENESIN,PSEUDOEPHEDRINE HCL | ACTIPHARMA, LLC | db0cb6ae-0a4d-4232-805a-f3f3a058261f | 2025-07-08 | Warnings | 6V9V2RYJ8N 495W7451VQ |
| Maximum Strength Hemorrhoidal Cream with Aloe | GLYCERIN, PHENYLEPHINE HCI, PRAMOXINE HCI, PETROLATUM | Chain Drug Marketing Association | 396ea654-8be1-591a-e063-6294a90a11e2 | 2025-07-08 | Warnings | PDC6A3C0OX |
| ACTICON | DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE | ACTIPHARMA, LLC | aea0335d-75e6-4a90-86a5-f197cf024a11 | 2025-07-08 | Warnings | 6V9V2RYJ8N |
| ACTINEL PEDIATRIC | DEXTROMETHORPHAN HBR,GUAIFENESIN,PSEUDOEPHEDRINE HCL | ACTIPHARMA, LLC | 6bb92d74-4893-40b8-af58-eb307155e876 | 2025-07-08 | Warnings | 6V9V2RYJ8N 495W7451VQ |
| ACTICON | DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE | ACTIPHARMA, LLC | 847014ab-86ae-40c5-8e7f-f1ddea14f1b3 | 2025-07-08 | Warnings | 6V9V2RYJ8N |
| Mucus Relief | GUAIFENESIN 400 MG | Cabinet Health, Inc. | 26a51b0e-039c-663c-e063-6394a90ad384 | 2025-07-07 | Warnings | 495W7451VQ |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Belleview Biosciences LLC | 3245e0e5-5e7f-c3f7-e063-6394a90ac258 | 2025-07-07 | Adverse reactions | 1Q73Q2JULR XF417D3PSL |
| MUCUS RELIEF | GUAIFENESIN 400 MG | Pioneer Life Sciences, LLC | 8188b66a-5405-4e62-bde6-63ebc1f22b16 | 2025-07-04 | Warnings | 495W7451VQ |
| Hemorrhoidal Cream | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 38cf4e43-280b-eb96-e063-6294a90a5949 | 2025-07-02 | Warnings | PDC6A3C0OX |
| basic care mucus er max | GUAIFENESIN | Amazon.com Services LLC | 3552346e-4650-44c1-9233-57251a029133 | 2025-07-02 | Warnings | 495W7451VQ |
| DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | KJD Pharma Private Limited | b109249a-a0be-41bd-b6ce-ef621b588ddc | 2025-07-02 | Warnings | 495W7451VQ |
| SEFUDUN FUNGAL NAIL PATCHES | GLYCERIN | Shenzhen Shandian Jingling Technology Co., Ltd. | 38db97d6-27c8-da99-e063-6294a90aac66 | 2025-07-01 | Warnings | PDC6A3C0OX |
| GUAIFENESIN | GUAIFENESIN | Advanced Rx LLC | cb7cd1df-8cfb-4a9c-9567-809a2343622e | 2025-07-01 | Warnings | 495W7451VQ |
| Mucus Relief DM Maximum Strength | GUAIFENESIN, DEXTROMETHORPHAN HBR | Chain Drug Consortium, LLC | d6aae1a1-0ab9-4b26-9f62-b8761014bb35 | 2025-06-30 | Warnings | 495W7451VQ |
| Mucus Relief DM Extended Release Caplets | GUAIFENESIN, DEXTROMETHORPHAN HBR | ATLANTIC BIOLOGICALS CORP. | 308f50dd-e8d6-0264-e063-6394a90afa68 | 2025-06-27 | Warnings | 495W7451VQ |
| Cough and Chest Congestion Maximum Strength | DEXTROMETHORPHAN HBR, GUAIFENESIN | Genexa Inc. | e920b700-30d3-3266-e053-2a95a90a0639 | 2025-06-24 | Warnings | 495W7451VQ |
| Mucinex D | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | A-S Medication Solutions | 7f9cc03f-7cc9-4e3b-9ba9-a8d0103b98c9 | 2025-06-23 | Warnings | 6V9V2RYJ8N 495W7451VQ |
| Glycerin Laxative | GLYCERIN LAXATIVE SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 35cc266a-196f-16ce-e063-6394a90a24af | 2025-06-20 | Warnings | PDC6A3C0OX |
| TYLENOL Cold Plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Morning Star OTC | be95332d-a2e0-42e8-bfb3-8850d74990ff | 2025-06-19 | Warnings | 495W7451VQ |
| Tylenol Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Morning Star OTC | 37e939c6-064b-3548-e063-6294a90a337d | 2025-06-19 | Warnings | 495W7451VQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.